We are live on ! Find out more
VPC

Vestal Point Capital Portfolio holdings

AUM $3.58B
1-Year Est. Return 190.75%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+190.75%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.58B
AUM Growth
+$851M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
113
New
Increased
Reduced
Closed

Top Buys

1
+$210M
2
+$166M
3
+$118M
4
ARWR icon
Arrowhead Research
ARWR
+$87M
5
IMCR icon
Immunocore
IMCR
+$70.6M

Top Sells

1
+$191M
2
+$144M
3
+$84.6M
4
MRK icon
Merck
MRK
+$81.6M
5
TYRA icon
Tyra Biosciences
TYRA
+$76.8M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VCYT icon
76
Veracyte
VCYT
$3.78B
$4.21M 0.12%
+130,687
ZBIO
77
Zenas BioPharma
ZBIO
$1.25B
$3.91M 0.11%
+200,000
GERN icon
78
Geron
GERN
$738M
$3.78M 0.11%
2,540,000
-8,780,000
MNPR icon
79
Monopar Therapeutics
MNPR
$400M
$3.58M 0.1%
+65,418
ZURA icon
80
Zura Bio
ZURA
$351M
$3.04M 0.09%
+511,000
NVCR icon
81
NovoCure
NVCR
$2.06B
$2.73M 0.08%
250,000
-275,000
NYXH
82
Nyxoah
NYXH
$139M
$2.54M 0.07%
868,661
-238,339
URGN icon
83
UroGen Pharma
URGN
$1.45B
$2.5M 0.07%
+139,079
PASG icon
84
Passage Bio
PASG
$18.6M
$2.39M 0.07%
305,000
TYRA icon
85
Tyra Biosciences
TYRA
$1.61B
$2.07M 0.06%
54,000
-2,371,000
RGNX icon
86
Regenxbio
RGNX
$344M
$909K 0.03%
108,525
+74,525
TENX icon
87
Tenax Therapeutics
TENX
$305M
$854K 0.02%
53,439
MGNX icon
88
MacroGenics
MGNX
$252M
$809K 0.02%
280,000
ABSI icon
89
Absci
ABSI
$1.06B
$697K 0.02%
+232,219
APRE icon
90
Aprea Therapeutics
APRE
$8.5M
$267K 0.01%
+350,000
ABT icon
91
Abbott
ABT
$154B
– –
-600,000
ACLX
92
DELISTED
Arcellx
ACLX
– –
-2,925,000
ALEC icon
93
Alector
ALEC
$170M
– –
-755,000
AXSM icon
94
Axsome Therapeutics
AXSM
$13.1B
– –
-210,000
BDTX icon
95
Black Diamond Therapeutics
BDTX
$100M
– –
-870,000
DAWN
96
DELISTED
Day One Biopharmaceuticals
DAWN
– –
-5,200,000
DBVT
97
DBV Technologies
DBVT
$1.03B
– –
-300,000
DXCM icon
98
DexCom
DXCM
$29.1B
– –
-1,275,000
FATE icon
99
Fate Therapeutics
FATE
$240M
– –
-1,725,000
GILD icon
100
Gilead Sciences
GILD
$156B
– –
-50,000
1 2 3
4
5